Why Is Tilray (TLRY) Stock Up 7% Today?

11:25am, Tuesday, 05'th Sep 2023
Tilray (NASDAQ: TLRY ) stock is climbing higher on Tuesday as investors continue to hold out hope for the decriminalization of marijuana. The excitement around decriminalization comes after a letter w
Tilray agreed to pay AB InBev $85 million in cash to acquire eight leading beer brands. The purchase will triple Tilray's beer business, making it the fifth-largest craft brewer in the U.S. It's a sma
In a previous article, I discussed Tilray's acquisition of Truss Beverage a company that makes cannabis infused beverages. Cannabis producers like Tilray (NASDAQ: TLRY ) often raise investor caution d

Time to Get High on Pot Stocks? (3 Catalysts)

10:33am, Friday, 01'st Sep 2023
When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.
Canopy Growth (CGC), Tilray (TLRY) and Cronos (CRON) shoot up on news that the DEA is considering recommendations for low-risk reclassification of marijuana.
Recently released macro economic data is indicating that the United States economy is heading for a “soft landing.” Specifically, according to the Department of Labor's  Job Openings and Labor Tu
If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q
Tilray (NASDAQ: TLRY ), a Canada-based cannabis company, is trending, and TLRY stock is up about 5% in early trading after jumping nearly 11% yesterday. The rally was sparked by a report that the U.S.
Cannabis stocks are up on Thursday as investors in the market react to news marijuana may be downgraded from a Schedule I drug. According to insiders, a member of the Department of Health and Human Se
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like
Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.
The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.

Why Tilray Stock Surged Today

03:52pm, Wednesday, 30'th Aug 2023
President Joe Biden is asking the DEA to reclassify marijuana as a Schedule III drug. The DEA has the authority to reschedule a drug under the Controlled Substances Act.
That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE